Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the public reaction to Jay Bhattacharya's appointment as NIH Director within 6 months?
Positive • 25%
Neutral • 25%
Negative • 25%
Mixed • 25%
Public opinion polls or surveys conducted by reputable polling organizations
COVID-19 Critic Jay Bhattacharya Emerges as Top Candidate for NIH Director
Nov 16, 2024, 07:24 PM
Jay Bhattacharya, a prominent critic of the National Institutes of Health (NIH), has emerged as a leading candidate to head the agency, according to a report by the Washington Post. Bhattacharya, who has been vocal about his views on COVID-19 policies, has garnered support from various quarters for his evidence-based criticism and intellectual rigor. His potential appointment has been met with enthusiasm by those who know him personally, citing his kindness, humility, and vision. Supporters believe Bhattacharya could transform the NIH and restore its credibility, which they feel has been compromised during the COVID-19 pandemic. Critics, including Francis Collins and Fauci, have previously labeled him a 'fringe epidemiologist,' but supporters argue he will uncover hidden secrets within the NIH.
View original story
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%
Mostly Positive • 25%
Mixed • 25%
Mostly Negative • 25%
Indifferent • 25%
Mostly Positive • 25%
Mostly Negative • 25%
Mixed • 25%
Neutral • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed reactions • 25%
Indifferent/No strong opinion • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed opinions • 25%
Indifferent • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Neutral • 25%
Confirmed • 25%
Rejected • 25%
Withdrawn • 25%
Pending • 25%
Confirmed • 33%
Rejected • 33%
Withdrawn • 34%
Yes • 50%
No • 50%
Increase in NIH funding for non-pharmaceutical research • 25%
Reduction in NIH collaborations with pharmaceutical companies • 25%
No significant changes in NIH leadership or policy • 25%
Other significant leadership changes • 25%
COVID-19 policies • 25%
Other • 25%
Transparency and accountability • 25%
Healthcare innovation • 25%
Appointed • 33%
Withdraws • 33%
Not appointed • 34%